Skip to main content

Table 3 Barthel Index categories at baseline and after follow-up (n = 143)

From: COVID-19 does not influence functional status after ARDS therapy

 

n

Total cohort (n = 143)

n

COVID-19 ARDS (n = 100)

n

Non-COVID-19 ARDS (n = 43)

Barthel index baseline

143

 

100

 

43

 

 Independence (100) n (%)

 

3 (2.1%)

 

3 (3.0%)

 

0 (0%)

 Slight dependency (91–99) n %)

 

0 (0%)

 

0 (0%)

 

0 (0%)

 Moderate dependency (61–90) n (%)

 

1 (0.7%)

 

0 (0%)

 

1 (2.3%)

 Severe dependency (21–60) n (%)

 

8 (5.6%)

 

4 (4.0%)

 

4 (9.3%)

 Total dependency (0–20) n (%)

 

131 (91.6%)

 

93 (93.0%)

 

38 (88.4%)

Barthel index 28 days

126

 

92

 

34

 

 Independence (100) n (%)

 

25 (19.8%)

 

23 (25%)

 

2 (5.9%)

 Slight dependency (91–99) n %)

 

4 (3.2%)

 

2 (2.2%)

 

2 (5.9%)

 Moderate dependency (61–90) n (%)

 

16 (12.7%)

 

10 (10.9%)

 

6 (17.6%)

 Severe dependency (21–60) n (%)

 

12 (9.5%)

 

7 (7.6%)

 

5 (14.7%)

 Total dependency (0–20) n (%)

 

69 (54.8%)

 

50 (54.3%)

 

29 (55.9%)

Barthel index 90 days

123

 

89

 

34

 

 Independence (100) n (%)

 

43 (35%)

 

32 (36%)

 

11 (32.4%)

 Slight dependency (91–99) n %)

 

3 (2.4%)

 

2 (2.2%)

 

1 (2.9%)

 Moderate dependency (61–90) n (%)

 

11 (8.9%)

 

8 (9.0%)

 

3 (8.8%)

 Severe dependency (21–60) n (%)

 

12 (9.8%)

 

8 (9.0%)

 

4 (11.8%)

 Total dependency (0–20) n (%)

 

54 (43.9%)

 

39 (43.8%)

 

15 (44.1%)

Barthel index 180 days

98

 

68

 

30

 

 Independence (100) n (%)

 

34 (34.7%)

 

24 (35.3%)

 

10 (33.3%)

 Slight dependency (91–99) n %)

 

2 (2%)

 

1 (1.5%)

 

1 (3.3%)

 Moderate dependency (61–90) n (%)

 

6 (6.1%)

 

4 (5.9%)

 

2 (6.7%)

 Severe dependency (21–60) n (%)

 

3 (3.1%)

 

0 (0%)

 

3 (10%)

 Total dependency (0–20) n (%)

 

53 (54.1%)

 

39 (57.4%)

 

14 (46.7%)

  1. Classification proposed by Shah et al. [21]